With over a decade serving the global pharmaceutical market and rapid expansion to include three renowned manufacturing sites with excellent regulatory records, Cenexi is a contract development and manufacturing organization (CDMO) that has rapidly built a strong reputation for its fill-finish expertise, innovation and high quality products.

Cenexi is sharply focused on surpassing customer expectations with its wide range of dosage forms, extensive capacity, deep technical and regulatory expertise, and commitment to exceptional customer service. Through our continuous improvement initiatives, Cenexi continues to build on its strong reputation for value, high quality, flexibility and timeliness of customer deliverables.


First of all, I want to thank our existing customers who renew their trust in us every day and the new customers who join us in this special industry.
In 2020, the health crisis due to COVID-19 has impacted the global organization and international needs for pharmaceuticals. Cenexi has been keen to and successful in maintaining close relationships with its customers during this period to be more than ever a trusted partner.
2021 promises to be unprecedented for Cenexi. Our Group is moving and transforming. Appointed Chairman in July 2020, I launched an ambitious dynamic of change and modernization of the Group, while continuing our efforts.
We will focus on strengthening our industrial excellence which has made us a key group in the sterile sector.
We will develop our service offering in development and industrial transfer to cover all of your needs, from A to Z.
We will strengthen the synergies between our sites to relieve your industrial problems.
2021 is the year of a new collaboration.

Christophe DURAND



Creation of Cenexi at the Fontenay-sous-Bois site, in Paris, France. It is a former production site of the Roche Group and a Center of Excellence for parenteral ampoules. Cenexi was a Roche Group affiliate, dedicated to contract manufacturing.


Cenexi became a completely independent company with one production site, located in Fontenay-sous-Bois. This site offers production capacity for parenteral ampoules, tablets, hard gelatin capsules, syrups and suppositories.


The Cenexi Group acquired a production site in Osny, dedicated to solids forms (tablets and hard gelatin capsules) for hormone products.

Our pharmaceutical development and product transfer departments merged their activities into a newly created entity: Cenexi Services, entirely dedicated to the pharmaceutical development of your product in any dosage form in the Cenexi portfolio.


The Cenexi Group acquired the Laboratoires Thissen production site located at Braine-l’Alleud in Belgium. This entity manufactures oncologic sterile products – freeze-dried vials and prefilled syringes.


Cenexi acquired the Hérouville-Saint-Clair site, near Caen in Normandy.

Specialized in manufacturing and filling sterile products such as syringes, vials and ampoules, the site also produces creams, ointments, lotions, syrups and drops.


Christophe Durand is the new CEO of Cenexi Group


- of which-


2020 Turnover
registered countries


Cenexi affirmed its commitment to a clean and healthy environment by securing ISO certification 14001 for its Cenexi and Cenexi Services entities located at Fontenay-sous-Bois in January 2012.

Cenexi approaches management of environmental issues as a process of continuous improvement. Cenexi continuously audits its practices in an effort to guide its activities, and to minimize any negative environmental impacts during the manufacture of its products and other activities.

The ISO14001 certification ensures that Cenexi abides by this initiative. By attaining this certification, Cenexi wishes to convey to its clients its commitment and responsibility towards a healthy environment and its continued protection.